JP2013531993A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013531993A5 JP2013531993A5 JP2013515568A JP2013515568A JP2013531993A5 JP 2013531993 A5 JP2013531993 A5 JP 2013531993A5 JP 2013515568 A JP2013515568 A JP 2013515568A JP 2013515568 A JP2013515568 A JP 2013515568A JP 2013531993 A5 JP2013531993 A5 JP 2013531993A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fragment
- seq
- influenza
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35597810P | 2010-06-17 | 2010-06-17 | |
| US61/355,978 | 2010-06-17 | ||
| US201161443103P | 2011-02-15 | 2011-02-15 | |
| US61/443,103 | 2011-02-15 | ||
| US201161445455P | 2011-02-22 | 2011-02-22 | |
| US61/445,455 | 2011-02-22 | ||
| PCT/US2011/040982 WO2011160083A1 (en) | 2010-06-17 | 2011-06-17 | Antibodies useful in passive influenza immuization |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013531993A JP2013531993A (ja) | 2013-08-15 |
| JP2013531993A5 true JP2013531993A5 (enExample) | 2014-07-31 |
| JP6050747B2 JP6050747B2 (ja) | 2016-12-21 |
Family
ID=45348575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013515568A Active JP6050747B2 (ja) | 2010-06-17 | 2011-06-17 | インフルエンザ受動免疫化に有用な抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10676520B2 (enExample) |
| EP (1) | EP2582721B1 (enExample) |
| JP (1) | JP6050747B2 (enExample) |
| KR (1) | KR101849738B1 (enExample) |
| CN (2) | CN106397584A (enExample) |
| AU (2) | AU2011268072C1 (enExample) |
| BR (1) | BR112012032185A2 (enExample) |
| CA (1) | CA2839421C (enExample) |
| DK (1) | DK2582721T3 (enExample) |
| ES (1) | ES2687706T3 (enExample) |
| RU (1) | RU2635999C2 (enExample) |
| WO (1) | WO2011160083A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013086052A2 (en) | 2011-12-05 | 2013-06-13 | Trellis Bioscience, Llc | Antibodies useful in passive influenza immunization |
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| EA201892509A1 (ru) | 2012-11-13 | 2019-04-30 | Дженентек, Инк. | Антитела к гемагглютинину и способы применения |
| US11827693B2 (en) | 2013-03-14 | 2023-11-28 | Contrafect Corporation | Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy |
| WO2015120097A2 (en) | 2014-02-04 | 2015-08-13 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
| US10639370B2 (en) * | 2014-02-04 | 2020-05-05 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
| WO2015140304A1 (en) * | 2014-03-20 | 2015-09-24 | Inflarx Gmbh | Inhibitors of c5a for the treatment of viral pneumonia |
| TWI702229B (zh) | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| EP3374390A1 (en) | 2015-11-13 | 2018-09-19 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| JP7104629B2 (ja) | 2016-02-24 | 2022-07-21 | ビステラ， インコーポレイテッド | インフルエンザウイルスに対する抗体分子の製剤 |
| CN109476728A (zh) | 2016-07-14 | 2019-03-15 | 生命北极公司 | 脑部递送蛋白 |
| EP3731862A1 (en) * | 2017-12-29 | 2020-11-04 | Development Center for Biotechnology | A universal vaccine against influenza |
| CA3088194A1 (en) | 2018-01-26 | 2019-08-01 | Regeneron Pharmaceuticals, Inc. | Human antibodies to influenza hemagglutinin |
| AU2020248404A1 (en) | 2019-03-25 | 2021-09-30 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235708B1 (en) | 1998-11-20 | 2001-05-22 | Zymogenetics, Inc | Testis-specific cystatin-like protein cystatin T |
| US20020006656A1 (en) | 1999-12-23 | 2002-01-17 | Holloway James L. | Zcys5: a member of the cystatin superfamily |
| US8420353B2 (en) | 2002-03-22 | 2013-04-16 | Aprogen, Inc. | Humanized antibody and process for preparing same |
| NZ542226A (en) | 2003-03-07 | 2008-08-29 | Merck & Co Inc | Influenza virus vaccine |
| KR101206206B1 (ko) | 2003-07-22 | 2012-11-29 | 크루셀 홀란드 비.브이. | 사스-코로나바이러스에 대한 결합분자 및 그것의 용도 |
| CN1934133B (zh) * | 2003-07-23 | 2011-12-14 | 富士瑞必欧株式会社 | 抗a型流感病毒单克隆抗体及使用该抗体的免疫测定器具 |
| US7413868B2 (en) | 2003-11-05 | 2008-08-19 | Trellis Bioscience, Inc. | Use of particulate labels in bioanalyte detection methods |
| US20080014205A1 (en) | 2006-05-15 | 2008-01-17 | Lawrence Horowitz | Neutralizing Antibodies to Influenza Viruses |
| US8192927B2 (en) | 2006-09-07 | 2012-06-05 | Crucell Holland B.V. | Human bind molecules capable of neutralizing influenza virus h5n1 and uses thereof |
| RU2448979C2 (ru) * | 2006-12-14 | 2012-04-27 | Ридженерон Фармасьютикалз, Инк. | Антитела человека к дельта-подобному лиганду-4 человека |
| EP3333187B1 (en) * | 2007-12-06 | 2022-06-22 | Dana-Farber Cancer Institute, Inc. | Antibodies against influenza virus and methods of use thereof |
| CA2719201A1 (en) * | 2008-03-28 | 2009-10-01 | Sea Lane Biotechnologies, Llc. | Neutralizing molecules to viral antigens |
| AU2009275226B2 (en) * | 2008-07-25 | 2015-05-14 | Institute For Research In Biomedicine | Neutralizing anti-influenza a virus antibodies and uses thereof |
| TW201019959A (en) | 2008-08-19 | 2010-06-01 | Regeneron Pharma | Human antibodies to human RANKL |
| CN102292350A (zh) | 2008-12-24 | 2011-12-21 | 淡马锡生命科学研究院有限公司 | 对来自甲型流感病毒血凝素的融合肽特异的单克隆抗体及其用途 |
| WO2011117848A1 (en) | 2010-03-26 | 2011-09-29 | Pomona Ricerca S.R.L. | Full-length immunoglobulins of the igg isotvpe capable of recognizing a heterosubtvpe neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament |
| EP2603237A4 (en) * | 2010-08-12 | 2014-05-21 | Theraclone Sciences Inc | ANTI-HEMAGGLUTININE ANTIBODY COMPOSITIONS AND METHOD FOR THEIR USE |
| WO2012045001A2 (en) * | 2010-09-30 | 2012-04-05 | Vanderbilt University | Influenza virus antibodies and immunogens and uses therefor |
-
2011
- 2011-06-17 JP JP2013515568A patent/JP6050747B2/ja active Active
- 2011-06-17 KR KR1020137001292A patent/KR101849738B1/ko not_active Expired - Fee Related
- 2011-06-17 EP EP11796555.8A patent/EP2582721B1/en active Active
- 2011-06-17 RU RU2013102073A patent/RU2635999C2/ru active
- 2011-06-17 WO PCT/US2011/040982 patent/WO2011160083A1/en not_active Ceased
- 2011-06-17 CN CN201610806357.8A patent/CN106397584A/zh active Pending
- 2011-06-17 AU AU2011268072A patent/AU2011268072C1/en not_active Ceased
- 2011-06-17 BR BR112012032185A patent/BR112012032185A2/pt not_active IP Right Cessation
- 2011-06-17 DK DK11796555.8T patent/DK2582721T3/en active
- 2011-06-17 CA CA2839421A patent/CA2839421C/en not_active Expired - Fee Related
- 2011-06-17 ES ES11796555.8T patent/ES2687706T3/es active Active
- 2011-06-17 CN CN201180035923.5A patent/CN103209994B/zh not_active Expired - Fee Related
- 2011-06-17 US US13/163,489 patent/US10676520B2/en active Active
-
2017
- 2017-06-09 AU AU2017203924A patent/AU2017203924B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013531993A5 (enExample) | ||
| AU2021245146B2 (en) | Influenza A virus specific antibodies | |
| CN104892753B (zh) | 一种中和人感染h7n9甲型流感病毒的抗体及其用途 | |
| Lee et al. | Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies | |
| RU2013102073A (ru) | Антитела, подходящие для пассивной иммунизации против гриппа | |
| HRP20201975T1 (hr) | Neutralizirajuća protutijela anti-influenca a virusa i njihova uporaba | |
| JP6371222B2 (ja) | インフルエンザの受動免疫用抗体 | |
| JP2011528901A5 (enExample) | ||
| HRP20161740T1 (hr) | Ljudske molekule za vezanje koje su sposobne neutralizirati viruse influence a filogenetske skupine 1 i filogenetske skupine 2, te viruse influence b | |
| JP2010521147A5 (enExample) | ||
| JP2014237714A5 (enExample) | ||
| JP2016503413A5 (enExample) | ||
| JP2010502207A5 (enExample) | ||
| JP2011528902A5 (enExample) | ||
| JP2015522252A5 (enExample) | ||
| JP2012526839A5 (enExample) | ||
| JP2013501807A5 (enExample) | ||
| US10610587B2 (en) | Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same | |
| CN105985433B (zh) | 针对h7n9亚型禽流感病毒的全人源单克隆抗体及应用 | |
| CN111094335A (zh) | 广泛中和的抗流感单克隆抗体及其用途 | |
| CN101993492B (zh) | 抗H5N1型高致病性禽流感scFv抗体及其应用 | |
| CN107216387B (zh) | 一种b型流感病毒广谱中和抗体、其制备方法及应用 | |
| Wu et al. | Allosteric Neutralization by Human H7N9 Antibodies | |
| Jia et al. | Allosteric Neutralization by Human H7N9 Antibodies | |
| Voronina et al. | Cross-reactive single-domain antibodies to hemagglutinin stem region protect mice from group 1 influenza A virus infection |